Regarding the prediction of recurrence and prognosis, the loss of Secreted frizzled-related protein-1 (SFRP1) was shown to indicate poor disease-free survival and OS for ICC patients through its effects on the Wnt-β-catenin pathway (Davaadorj et al., 2017). Here, SFRP1 is linked to intrahepatic cholangiocarcinoma.